Table 5.

Baseline features of the trials included

Trial name	Mean age	Males (%)	Ht (%)	Ds (%)	Cs (%)	DM (%)
	ZES/EES	ZES/EES	ZES/EES	ZES/EES	ZES/EES	ZES/EES
DUTCH PEERS [17]	64.0/65.0	73.0/73.0	55.0/53.0	46.0/48.0	24.0/26.0	18.0/17.0
HOST-ASSURE [18]	63.5/63.1	65.6/69.8	68.1/68.2	65.7/64.0	29.5/32.9	32.0/31.8
Lin 2015 [15]	63.0/65.5	72.8/73.4	71.9/69.6	59.3/57.4	64.8/51.4	25.5/25.2
Mehilli 2013 [16]	69.4/70.2	72.8/77.3	68.2/69.9	68.8/75.8	14.8/13.2	28.4/28.5
RESOLUTE [19]	64.4/64.2	76.7/77.2	71.1/71.3	63.9/67.7	26.5/26.5	23.5/23.4
TWENTE [20]	63.9/64.5	72.5/72.5	55.4/55.8	57.0/61.4	25.3/23.6	22.7/20.6

Abbreviations: Ht hypertension, Ds dyslipidemia, Cs current smoker, DM diabetes mellitus, ZES zotarolimus eluting stents, EES everolimus eluting stents